L. Ainsi and . Phéno, AAT dans les cohortes de tels patients peut être motivé d'un point de vue de la recherche

. En, ont décrit pour la première fois l'association du déficit sévère et moyen en AAT avec la vascularite systémique anti-PR3 positif (65), et considéré le rôle pathogénétique du déficit en AAT et l'apparition d'ANCA, avec une spécificité pour la

L. Protéinase, PR3) est une sérine protéase élastase neutrophile-like, localisée dans les granules des polynucléaires neutrophiles, et dont l'AAT est l

P. La, antigène cible principal des anticorps anticytoplasme des polynucléaires neutrophiles (ANCA) qui sont impliqués dans la pathogénèse des vascularites nécrosantes touchant les petits vaisseaux, particulièrement dans la granulomatose de Wegener (GW) et la polyangéite microscopique (PAM)

M. Luisetti and N. Seersholm, ??1-Antitrypsin deficiency {middle dot} 1: Epidemiology of ??1-antitrypsin deficiency, Thorax, vol.59, issue.2, pp.164-173, 2004.
DOI : 10.1136/thorax.2003.006494

F. De-serres, Worldwide Racial and Ethnic Distribution of ??1-Antitrypsin Deficiency, Chest, vol.122, issue.5, pp.1818-1847, 2002.
DOI : 10.1378/chest.122.5.1818

I. Blanco, F. De-serres, E. Fernandez-bustillo, B. Lara, and M. Miravitlles, Estimated numbers and prevalence of PI*S and PI*Z alleles of ??1-antitrypsin deficiency in European countries, European Respiratory Journal, vol.27, issue.1, pp.77-84, 2006.
DOI : 10.1183/09031936.06.00062305

F. De-serres, I. Blanco, and E. Fernández-bustillo, Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of alpha1-antitrypsin deficiency in Asia, Eur Respir J, 2006.

D. Demeo and E. Silverman, Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha1- antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk, Thorax, 2004.

M. Needham and R. Stockley, ??1-Antitrypsin deficiency * 3: Clinical manifestations and natural history, Thorax, vol.59, issue.5, pp.441-446, 2004.
DOI : 10.1136/thx.2003.006510

D. Lomas and H. Parfrey, ??1-Antitrypsin deficiency * 4: Molecular pathophysiology, Thorax, vol.59, issue.6, pp.529-564, 2004.
DOI : 10.1136/thx.2003.006528

M. Brantly, T. Nukiwa, and R. Crystal, Molecular basis of alpha-1-antitrypsin deficiency, The American Journal of Medicine, vol.84, issue.6A, pp.13-31, 1988.
DOI : 10.1016/S0002-9343(88)80066-4

M. Owen, S. Brennan, J. Lewis, and R. Carrell, Mutation of Antitrypsin to Antithrombin, New England Journal of Medicine, vol.309, issue.12, pp.694-702, 1983.
DOI : 10.1056/NEJM198309223091203

T. Sveger, -Antitrypsin Deficient Children, Acta Paediatrica, vol.78, issue.6, pp.847-51, 1988.
DOI : 10.1001/jama.254.21.3036

T. Sveger, E. Piitulainen, M. Arborelius, and . Jr, Lung function in adolescents with ??1-antitrypsin deficiency, Acta Paediatrica, vol.136, issue.11, pp.1170-1173, 1994.
DOI : 10.1164/ajrccm/136.3.740

T. Sveger and S. Eriksson, The liver in adolescents with alpha 1-antitrypsin deficiency, Hepatology, vol.22, issue.2, pp.514-521, 1995.

J. Stoller and L. Aboussouan, ??1-Antitrypsin deficiency {middle dot} 5: Intravenous augmentation therapy: current understanding, Thorax, vol.59, issue.8, pp.708-720, 2004.
DOI : 10.1136/thx.2003.006544

E. Piitulainen and T. Sveger, Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ). Thorax, pp.705-713, 2002.

E. Piitulainen, J. Carlson, K. Ohlsson, and T. Sveger, ??1-Antitrypsin Deficiency in 26-Year-Old Subjects, Chest, vol.128, issue.4, pp.2076-81, 2005.
DOI : 10.1378/chest.128.4.2076

E. Bernspång, T. Sveger, and E. Piitulainen, Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency, Respiratory Medicine, vol.101, issue.9, pp.1971-1977, 2007.
DOI : 10.1016/j.rmed.2007.04.003

H. Takahashi, T. Nukiwa, K. Satoh, F. Ogushi, M. Brantly et al., Characterization of the gene and protein of the alpha 1-antitrypsin "deficiency" allele Mprocida, J Biol Chem, vol.263, issue.30, pp.15528-15562, 1988.

E. Bernspång, P. Wollmer, T. Sveger, and E. Piitulainen, Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals, Respiratory Medicine, vol.103, issue.6, pp.861-866, 2009.
DOI : 10.1016/j.rmed.2008.12.021

D. Curiel, M. Holmes, H. Okayama, M. Brantly, C. Vogelmeier et al., Molecular basis of the liver and lung disease associated with the alpha 1- antitrypsin deficiency allele Mmalton, J Biol Chem, vol.264, issue.23, pp.13938-13983, 1989.

D. Curiel, C. Vogelmeier, R. Hubbard, L. Stier, and R. Crystal, Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele., Molecular and Cellular Biology, vol.10, issue.1, pp.47-56, 1990.
DOI : 10.1128/MCB.10.1.47

M. Hofker, T. Nukiwa, H. Van-paassen, M. Nelen, J. Kramps et al., A Pro ??? Leu substitution in codon 369 of the alpha-1-antitrypsin deficiency variant PI MHeerlen, Human Genetics, vol.81, issue.3, pp.264-272, 1989.
DOI : 10.1007/BF00279001

K. Takabe, K. Seyama, H. Shinada, T. Nouchi, Y. Miyahara et al., A New Variant of Alpha-1-Antitrypsin Deficiency (Siiyama) Associated with Pulmonary Emphysema., Internal Medicine, vol.31, issue.5, pp.702-709, 1992.
DOI : 10.2169/internalmedicine.31.702

T. Nukiwa, K. Seyama, H. Takahashi, and K. S. , Alpha 1-antitrypsin genes in patients with alpha 1AT deficiency in Japan: mutational analysis and allelic background, Nihon Kyobu Shikkan Gakkai Zasshi, vol.30, issue.8, pp.1420-1426, 1992.

R. Carrell, D. Lomas, S. Sidhar, and R. Foreman, ??1-Antitrypsin Deficiency, Chest, vol.110, issue.6, pp.243-247, 1996.
DOI : 10.1378/chest.110.6_Supplement.243S

D. Lomas, A. Lourbakos, S. Cumming, and D. Belorgey, -antitrypsin deficiency and dementia, Biochemical Society Transactions, vol.30, issue.2, pp.89-92
DOI : 10.1042/bst0300089

R. Carrell and D. Lomas, -Antitrypsin Deficiency ??? A Model for Conformational Diseases, New England Journal of Medicine, vol.346, issue.1, pp.45-53, 2002.
DOI : 10.1056/NEJMra010772

D. Lomas, -Antitrypsin Deficiency, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.10, pp.1072-1079, 2006.
DOI : 10.1164/rccm.200511-1797PP

A. Lachaux and J. Dumortier, Atteinte h??patique du d??ficit h??r??ditaire en alpha-1-antitrypsine, Revue des Maladies Respiratoires, vol.31, issue.4, pp.357-64
DOI : 10.1016/j.rmr.2013.10.651

A. Duvoix, B. Roussel, and D. Lomas, Molecular pathogenesis of alpha-1-antitrypsin deficiency, Revue des Maladies Respiratoires, vol.31, issue.10, pp.992-1002, 2014.
DOI : 10.1016/j.rmr.2014.03.015

C. De-seynes, C. Ged, H. De-verneuil, N. Chollet, M. Balduyck et al., Identification of a novel alpha1-antitrypsin variant, Respiratory Medicine Case Reports, vol.20, pp.64-67, 2016.
DOI : 10.1016/j.rmcr.2016.11.008

. Société-de-pneumologie-de-langue-française, Recommendation for the clinical practice management of COPD, Rev Mal Respir, vol.27, issue.5, pp.522-570, 2010.

M. Zysman, F. Chabot, P. Devillier, B. Housset, C. Morelot-panzini et al., Société de Pneumologie de Langue Française (SPLF) Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue Française, Rev Mal Respir, issue.10, pp.911-936, 2016.

E. Bernspång, S. Diaz, B. Stoel, P. Wollmer, T. Sveger et al., CT lung densitometry in young adults with alpha-1-antitrypsin deficiency, Respiratory Medicine, vol.105, issue.1, pp.74-83, 2011.
DOI : 10.1016/j.rmed.2010.06.016

H. Tanash, M. Nystedt-düzakin, L. Montero, T. Sveger, and E. Piitulainen, -Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34, Annals of the American Thoracic Society, vol.12, issue.6, pp.807-819, 2015.
DOI : 10.1513/AnnalsATS.201410-452OC

J. Traclet, P. Delaval, P. Terrioux, and J. Mornex, Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema, Revue des Maladies Respiratoires, vol.32, issue.4, pp.435-481
DOI : 10.1016/j.rmr.2014.10.001

URL : https://hal.archives-ouvertes.fr/hal-01146841

J. Stoller, F. Rouhani, M. Brantly, S. Shahin, R. Dweik et al., Biochemical Efficacy and Safety of a New Pooled Human Plasma ??1-Antitrypsin, Respitin, Chest, vol.122, issue.1, pp.66-74, 2002.
DOI : 10.1378/chest.122.1.66

N. Seersholm, M. Wencker, N. Banik, K. Viskum, A. Dirksen et al., Does ??<SUB>1</SUB>-antitrypsin augmentation therapy slow the annual decline in FEV<SUB>1</SUB> in patients with severe hereditary ??<SUB>1</SUB>-antitrypsin deficiency?, European Respiratory Journal, vol.10, issue.10, pp.2260-2263, 1997.
DOI : 10.1183/09031936.97.10102260

J. Stoller, R. Fallat, M. Schluchter, O. Brien, R. Connor et al., Augmentation Therapy With ??1-Antitrypsin, Chest, vol.123, issue.5, pp.1425-1459, 2003.
DOI : 10.1378/chest.123.5.1425

M. Wencker, N. Banik, R. Buhl, R. Seidel, and N. Konietzko, Long-term treatment of alpha1- antitrypsin deficiency-related pulmonary emphysema with human, p.1

W. Arbeitsgemeinschaft-zur-therapie-von-lungenerkrankungen, WATL)-alpha1- AT-study group, Eur Respir J. Feb, vol.11, issue.2, pp.428-461, 1998.

H. Tanash, G. Riise, L. Hansson, P. Nilsson, and E. Piitulainen, Survival benefit of lung transplantation in individuals with severe ??1-anti-trypsin deficiency (PiZZ) and emphysema, The Journal of Heart and Lung Transplantation, vol.30, issue.12, pp.1342-1349, 2011.
DOI : 10.1016/j.healun.2011.07.003

H. Stone, R. Edgar, R. Thompson, and R. Stockley, Lung Transplantation in Alpha-1-Antitrypsin Deficiency, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.55, issue.8, pp.146-52, 2016.
DOI : 10.1136/thorax.58.12.1020

R. Yusen, J. Christie, L. Edwards, A. Kucheryavaya, C. Benden et al., The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report???2013; Focus Theme: Age, The Journal of Heart and Lung Transplantation, vol.32, issue.10, pp.965-78, 2013.
DOI : 10.1016/j.healun.2013.08.007

D. Wolf, J. Bonnette, P. Sage, É. Hamid, and A. , What place for lung volume reduction surgery for emphysema? Rev Mal Respir, Feb, vol.34, issue.2, pp.147-154, 2017.

C. Strife, G. Hug, C. G. Mcadams, A. Davis, C. Kline et al., Membranoproliferative glomerulonephritis and alpha 1-antitrypsin deficiency in children, Pediatrics, vol.71, issue.1, pp.88-92, 1983.

V. Esnault, A. Testa, M. Audrain, C. Rogé, M. Hamidou et al., Alpha1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis, Kidney International, vol.43, issue.6, pp.1329-1361, 1993.
DOI : 10.1038/ki.1993.186

V. Esnault, ANCA-positive vasculitis and alpha 1-antitrypsin deficiency: could free ANCA antigens released b neutrophils mediate vasculitic lesions?, Nephrology Dialysis Transplantation, vol.12, issue.2, 1997.
DOI : 10.1093/ndt/12.2.249

I. Os, F. Skjørten, C. Svalander, and E. Berge, Alpha-1-Antitrypsin Deficiency Associated with Hepatic Cirrhosis and IgA Nephritis, Nephron, vol.77, issue.2, pp.235-242, 1997.
DOI : 10.1159/000190278

I. Davis, B. Burke, D. Freese, H. Sharp, and Y. Kim, The pathologic spectrum of the nephropathy associated with ??1-antitrypsin deficiency, Human Pathology, vol.23, issue.1, pp.57-62, 1992.
DOI : 10.1016/0046-8177(92)90012-R

K. Smith, W. Su, M. Pittelkow, and R. Winkelmann, Clinical and pathologic correlations in 96 patients with panniculitis, including 15 patients with deficient levels of ??1-antitrypsin, Journal of the American Academy of Dermatology, vol.21, issue.6, pp.1192-1198, 1989.
DOI : 10.1016/S0190-9622(89)70328-5

G. Deest, S. Ahmed, and X. Causse, Insuffisance pancr??atique exocrine r??v??lant un d??ficit en alpha-1-antitrypsine, Gastroent??rologie Clinique et Biologique, vol.32, issue.11, pp.906-915, 2008.
DOI : 10.1016/j.gcb.2008.06.007

R. Sandhaus, ??1-Antitrypsin deficiency {middle dot} 6: New and emerging treatments for ??1-antitrypsin deficiency, Thorax, vol.59, issue.10, pp.904-913, 2004.
DOI : 10.1136/thx.2003.006551

E. Piitulainen, B. Mostafavi, and H. Tanash, Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years, International Journal of Chronic Obstructive Pulmonary Disease, vol.12, issue.2, pp.495-500, 2017.
DOI : 10.2147/COPD.S120241

B. Mostafavi, S. Diaz, H. Tanash, and E. Piitulainen, Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age, Medicine, vol.96, issue.12, p.6180, 2017.
DOI : 10.1097/MD.0000000000006180

E. Piitulainen and T. Sveger, Effect of environmental and clinical factors on lung function and respiratory symptoms in adolescents with alpha1-antitrypsin deficiency, Acta Paediatr, 1998.

E. Piitulainen and H. Tanash, The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.19, issue.5, pp.36-41
DOI : 10.1183/09031936.00159408

G. Thabut, Cohorte nationale de patients emphys??mateux d??ficitaires en alpha-1 antitrypsine, Revue des Maladies Respiratoires, vol.22, issue.6, pp.1053-1060, 2005.
DOI : 10.1016/S0761-8425(05)85738-9

G. Thabut, J. Mornex, A. Cuvelier, B. Padrazzi, C. Pison et al., Caract??ristiques des patients inclus dans la cohorte fran??aise de patients emphys??mateux d??ficitaires en alpha-1 antitrypsine, Revue des Maladies Respiratoires, vol.25, issue.9, pp.1115-1137, 2008.
DOI : 10.1016/S0761-8425(08)74982-9

R. Stockley, M. Luisetti, M. Miravitlles, E. Piitulainen, and P. Fernandez, Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development, European Respiratory Journal, vol.29, issue.3, pp.582-588, 2007.
DOI : 10.1183/09031936.00053606

K. Viskum and J. Stolk, A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy, Am J Respir Crit Care Med, vol.160, issue.5, pp.1468-72, 1999.

P. Dawkins, C. Dawkins, A. Wood, P. Nightingale, J. Stockley et al., Rate of progression of lung function impairment in alpha1-antitrypsin deficiency, Eur Respir J, 2009.

R. Stockley, D. Parr, E. Piitulainen, J. Stolk, B. Stoel et al., Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry, Respiratory Research, vol.88, issue.3 pt 1, p.136, 2010.
DOI : 10.2522/ptj.20070147

H. Tanash, P. Nilsson, J. Nilsson, and E. Piitulainen, Clinical course and prognosis of neversmokers with severe alpha-1-antitrypsin deficiency (PiZZ). Thorax, pp.1091-1096, 2008.

H. Tanash, P. Nilsson, J. Nilsson, and E. Piitulainen, Survival in severe alpha-1-antitrypsin deficiency (PiZZ) Respir Res, p.44, 2010.

H. Tanash, M. Ekström, P. Wagner, and E. Piitulainen, Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden, International Journal of Chronic Obstructive Pulmonary Disease, vol.11, pp.1663-1672, 2016.
DOI : 10.2147/COPD.S109173

J. Stoller, J. Tomashefski, . Jr, R. Crystal, A. Arroliga et al., Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry, Chest, vol.127, issue.4, pp.1196-204, 2005.

B. Fournier and . Aitilalne, Déclin du VEMS des emphysémateux déficitaires en alpha-1 antitrysine, Revue des maladies respiratoires, vol.33, pp.18-19, 2016.

M. Needham and R. Stockley, Exacerbations in ??1-antitrypsin deficiency, European Respiratory Journal, vol.25, issue.6, pp.992-1000, 2005.
DOI : 10.1183/09031936.05.00074704

E. Piitulainen and S. Eriksson, Decline in FEV1 related to smoking status in individuals with severe ??<SUB>1</SUB>-antitrypsin deficiency (PiZZ), European Respiratory Journal, vol.13, issue.2, pp.247-51, 1999.
DOI : 10.1183/09031936.99.13224799

D. Demeo, R. Sandhaus, A. Barker, M. Brantly, E. Eden et al., Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency, Thorax, vol.62, issue.9, 2007.
DOI : 10.1136/thx.2006.075846

E. Piitulainen, G. Tornling, and S. Eriksson, Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ), Thorax, vol.52, issue.3
DOI : 10.1136/thx.52.3.244

E. Piitulainen, G. Tornling, and S. Eriksson, Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ), Thorax, vol.53, issue.11, pp.939-982, 1998.
DOI : 10.1136/thx.53.11.939

A. Mayer, J. Stoller, B. Bucher-bartelson, J. Ruttenber, A. Sandhaus et al., -Antitrypsin Deficiency, American Journal of Respiratory and Critical Care Medicine, vol.162, issue.2, pp.553-561, 2000.
DOI : 10.1164/ajrccm.162.2.9907117

O. Senn, E. Russi, and M. Imboden, Probst-Hensch NM. alpha1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants, Eur Respir J, 2005.

M. Schluchter, J. Stoller, A. Barker, A. Buist, R. Crystal et al., -Antitrypsin Deficiency, American Journal of Respiratory and Critical Care Medicine, vol.161, issue.3, pp.796-801, 2000.
DOI : 10.1164/ajrccm.161.3.9906011

M. Wencker, B. Fuhrmann, N. Banik, N. Konietzko, and . Arbeitsgemeinschaft-zur-therapie-von-lungenerkrankungen, Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor, Chest, 2001.

K. Chapman, R. Stockley, C. Dawkins, M. Wilkes, and R. Navickis, Antitrypsin Deficiency: A Meta-Analysis, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.158, issue.3, pp.177-84, 2009.
DOI : 10.1056/NEJM199708213370806

H. Teschler, -antitrypsin deficiency: 25???years of augmentation therapy, European Respiratory Review, vol.24, issue.135, pp.46-51, 2015.
DOI : 10.1183/09059180.10010714

L. Dowson, P. Guest, and R. Stockley, Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline

R. Vidal, I. Blanco, F. Casas, R. Jardí, and M. Miravitlles, Committee on the National Registry of Individuals with Alpha-1 Antitrypsin Deficiency. Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency, Arch Bronconeumol, vol.42, issue.12, pp.645-59, 2006.

A. Dirksen, E. Piitulainen, D. Parr, C. Deng, M. Wencker et al., Exploring the role of CT densitometry: a randomised study of augmentation therapy in ??1-antitrypsin deficiency, European Respiratory Journal, vol.33, issue.6, pp.1345-53, 2009.
DOI : 10.1183/09031936.00159408

J. Stoller and L. Aboussouan, -Antitrypsin Deficiency, American Journal of Respiratory and Critical Care Medicine, vol.185, issue.3, pp.246-59
DOI : 10.1164/rccm.201108-1428CI

A. Cuvelier and J. Mornex, Le d??ficit en alpha-1??antitrypsine??: avanc??es des connaissances et questions restantes, Revue des Maladies Respiratoires, vol.31, issue.4, pp.295-304
DOI : 10.1016/j.rmr.2014.04.087

M. Snyder, J. Katzmann, M. Butz, C. Wiley, P. Yang et al., Diagnosis of ??-1-Antitrypsin Deficiency: An Algorithm of Quantification, Genotyping, and Phenotyping, Clinical Chemistry, vol.52, issue.12, pp.2236-2278, 2006.
DOI : 10.1373/clinchem.2006.072991

R. Abboud, T. Nelson, B. Jung, and A. Mattman, Alpha1-antitrypsin deficiency, Respiratory Medicine: COPD Update, vol.1, issue.3, pp.55-65, 2011.
DOI : 10.1016/j.rmedu.2006.01.027

J. Mornex, Alpha-1 antitrypsin deficiency 50 years later, Bull Acad Natl Med, vol.198, pp.4-5757, 2014.

S. Eriksson, Alpha 1-antitrypsin deficiency: lessons learned from the bedside to the gene and back again. Historic perspectives. Chest, pp.181-190, 1989.

C. Laurell and S. Eriksson, -Antitrypsin Deficiency, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.5, issue.9, pp.3-8, 1963.
DOI : 10.1016/B978-0-12-395720-7.50008-0

M. Balduyck, M. Odou, F. Zerimech, N. Porchet, J. Lafitte et al., Diagnosis of alpha-1 antitrypsin deficiency: Modalities, indications and diagnosis strategy, Revue des Maladies Respiratoires, vol.31, issue.8, 2014.
DOI : 10.1016/j.rmr.2014.06.001

D. Greene, M. Elliott-jelf, J. Straseski, and D. Grenache, Facilitating the Laboratory Diagnosis of ??1-Antitrypsin Deficiency, American Journal of Clinical Pathology, vol.139, issue.2, pp.184-91, 2013.
DOI : 10.1309/AJCP6XBK8ULZXWFP

J. Stoller, Alpha-1 antitrypsin deficiency: An underrecognized, treatable cause of COPD, Cleveland Clinic Journal of Medicine, vol.83, issue.7
DOI : 10.3949/ccjm.83a.16031

S. Shaker, T. Stavngaard, J. Stolk, B. Stoel, and A. Dirksen, ??1-Antitrypsin deficiency {middle dot} 7: Computed tomographic imaging in ??1-antitrypsin deficiency, Thorax, vol.59, issue.11, pp.986-91, 2004.
DOI : 10.1136/thorax.2003.006569

J. Lieberman, Augmentation Therapy Reduces Frequency of Lung Infections in Antitrypsin Deficiency, Chest, vol.118, issue.5, pp.1480-1485, 2000.
DOI : 10.1378/chest.118.5.1480

J. Wilson and J. Galvin, Normal diffusing capacity in patients with PiZ alpha(1)-antitrypsin deficiency, severe airflow obstruction, and significant radiographic emphysema, Chest, 2000.

H. De-cremoux, C. Defouilloy, and J. Bignon, Emphys??me pulmonaire Grands syndromes anatomocliniques, EMC - Pneumologie, vol.1, issue.1, 2003.
DOI : 10.1016/S1155-195X(03)00076-8

L. Monnier-cholley and . Arrivé, Tomodensitométrie du thorax, EMC Pneumologie, 2004.

C. Raherison and P. Girodet, Facteurs ??tiologiques et ??pid??miologie des bronchopneumopathies chroniques obstructives (BPCO), EMC - Pneumologie, vol.6, issue.1, 2009.
DOI : 10.1016/S1155-195X(09)39284-1

K. Chapman, J. Burdon, E. Piitulainen, R. Sandhaus, N. Seersholm et al., Intravenous augmentation treatment and lung density in severe ??1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial, The Lancet, vol.386, issue.9991, pp.360-368, 2015.
DOI : 10.1016/S0140-6736(15)60860-1

N. Mcelvaney, J. Burdon, M. Holmes, A. Glanville, P. Wark et al., RAPID Extension Trial Group. Long-term efficacy and safety of ?1 proteinase inhibitor treatment for emphysema caused by severe ?1 antitrypsin deficiency: an openlabel extension trial (RAPID-OLE), Lancet Respir Med, vol.5, issue.1, pp.201751-60

J. Traclet, P. Camus, M. Pujazon, and J. Mornex, Traitement substitutif prolongé du déficit en alpha-1 antitrypsine. Revue des maladies respiratoires 2013, pp.133-134

T. Craig, Suspecting and Testing for Alpha-1 Antitrypsin Deficiency???An Allergist's and/or Immunologist's Perspective, The Journal of Allergy and Clinical Immunology: In Practice, vol.3, issue.4, pp.506-517, 2015.
DOI : 10.1016/j.jaip.2015.04.005

J. Stoller, R. Sandhaus, G. Turino, R. Dickson, K. Rodgers et al., Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem, Chest, 2005.

A. Cuvelier, Le déficit en alpha-1 antitrypsine. Rev Mal Respir, pp.7-17, 2007.

R. Taliercio, R. Chatburn, and J. Stoller, Knowledge of alpha-1 antitrypsin deficiency among internal medicine house officers and respiratory therapists: results of a survey. Respir Care, pp.322-329, 2010.

H. Thabut, Moutaffian Évaluation des pratiques de prescription du dosage pondéral de l'alpha-1 antitrypsine, Revue des Maladies Respiratoires, vol.31, pp.71-72

J. Stoller and M. Brantly, The Challenge of Detecting Alpha-1 Antitrypsin Deficiency, COPD: Journal of Chronic Obstructive Pulmonary Disease, vol.9, issue.sup1, pp.26-34, 2013.
DOI : 10.1016/S0954-6111(99)90003-3